MAPT and Alzheimer disease: Mechanically, DAPK1 can phosphorylate and inhibit the activity of Pin1, a peptidyl-prolyl cis/trans isomerase that converts cis to trans p-tau to prevent a group of tau pathologies, including AD [8,85,86,87].